The Teva-Handok business venture is expected to commence activities in the middle of this month.
Last December, Teva Pharmaceutical Industries and Handok Pharmaceutical announced their agreement to establish a business venture in Korea, allowing Teva to gain entrance into the Korean pharmaceutical market, currently valued at approximately US$14 billion.
Under the terms of the agreement, ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.